Skip to main content
SpringerLink
Log in

Diabetes Mellitus

  • Chapter
Fundamentals of Family Medicine

  • 234 Accesses

Abstract

Diabetes mellitus (DM) affects 12 million to 15 million individuals in the United States, incurring an immense cost in terms of morbidity and premature death. The most prevalent form, type 2 DM, previously called adult-onset DM, has racial preponderances, female predilection, and strong associations with obesity. During the 1980s there was a revolution in DM management with the advent of home blood glucose monitoring devices, human insulin, and reliable laboratory markers of long-term glycemic control. Additionally, published national and international standards of care have been disseminated directly to patients and physicians, heightening the importance of adequate care and glycemic control to minimize devastating long-term complications.1,2 Table 20.1 describes diagnostic criteria for diabetes mellitus, impaired glucose tolerance, and gestational diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Clinical practice recommendations: 2001. Diabetes Care 2001;24(suppl 1 ): S1 — S133.

    Google Scholar 

  2. The European patient’s charter. Diabetic Med 1991; 8: 782–3.

    Article  Google Scholar 

  3. Landin-Olsson M, Nilsson KO, Lernmark A, Sunkvist G. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetalogia 1990; 33: 561–8.

    Article  CAS  Google Scholar 

  4. Zeigler AG, Herskowitz RD, Jackson RA, Soeldner JS, Eisenbarth GS. Predicting type I diabetes. Diabetes Care 1990; 13: 762–75.

    Google Scholar 

  5. Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type I diabetes. N Engl J Med 1993; 341: 927–8.

    CAS  Google Scholar 

  6. Shapiro AMJ, Lakey BS, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230–8.

    Article  PubMed  CAS  Google Scholar 

  7. Helnuich SP, Ragland DR, Leung RW, Paffenbarger RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991; 325: 147–52.

    Article  Google Scholar 

  8. UKPDS Group. UK prospective diabetes study XI: biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabetic Med 1994; 11: 533–44.

    Google Scholar 

  9. DeFronzo RA. The triumvirate: B-cell, muscle, and liver: a collusion responsible for NIDDM. Diabetes 1988; 37: 667–87.

    PubMed  CAS  Google Scholar 

  10. Erikkson J, Franssila-Kallunki A, Ekstrand A. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337–43.

    Article  Google Scholar 

  11. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. Diabetes Care 1992; 15: 318–68.

    Article  PubMed  CAS  Google Scholar 

  12. Clark PM, Hales CN. Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabetic Med 1992; 9: 503–12.

    Article  PubMed  Google Scholar 

  13. Bjornstorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132–43.

    Article  Google Scholar 

  14. Ferrannini E, Buzzigoli G, Bonadonna B, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–7.

    Article  PubMed  CAS  Google Scholar 

  15. Zavaroni I, Bonora E, Pagliara M, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989; 320: 703–6.

    Article  Google Scholar 

  16. Kern TS, Engerman RL. Arrest of glomerulonephropathy in diabetic dogs by improved glycemic control. Diabetologia 1990; 33: 522–5.

    Article  PubMed  CAS  Google Scholar 

  17. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.

    Article  Google Scholar 

  18. UKPDS Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.

    Article  Google Scholar 

  19. UKPDS Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–11.

    Google Scholar 

  20. UKPDS Group. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412–9.

    Google Scholar 

  21. National committee for clinical laboratory standards. Development of designated comparison methods for analytes in the clinical laboratory, 2nd ed., proposed guideline. NCCLS publication NRSCL6–P2. Villanova, PA: NCCLS, 1993.

    Google Scholar 

  22. Viberti GC. Etiology and prognostic significance of albuminuria in diabetes. Diabetes Care 1988; 11: 840–8.

    Article  PubMed  CAS  Google Scholar 

  23. Deckert T, Feldt-Rasmussen B, Borch-Johnson K, Jensen T, Kofoed-Gnevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 1989; 32: 219–26.

    Article  PubMed  CAS  Google Scholar 

  24. Marshall SM. Screening for microalbuminuria: which measurement? Diabetic Med 1991; 8: 706–11.

    Article  PubMed  CAS  Google Scholar 

  25. Hamwi GL. Changing dietary concepts in therapy. In: Danowski TS, ed. Diabetes mellitus: diagnosis and treatment. New York: American Diabetes Association, 1964; 73–8.

    Google Scholar 

  26. Wood FC, Bierman EL. Is diet the cornerstone in management of diabetes? N Engl J Med 1986; 1244–7.

    Google Scholar 

  27. Zehrer C, Hansen R, Bantl J. Reducing blood glucose variability by use of abdominal injection sites. Diabetes Educator 1990; 16: 474–7.

    Article  PubMed  CAS  Google Scholar 

  28. Skyler JS, Skyler DL, Seigler DE, O’Sullivan M. Algorithms for adjustment of insulin dosage by patients who monitor blood glucose. Diabetes Care 1981; 4: 311–8.

    Article  PubMed  CAS  Google Scholar 

  29. Frykberg RG. Management of diabetic foot problems (Joslin Clinic). Philadelphia: Saunders, 1984.

    Google Scholar 

  30. Singerman LJ. Early-treatment diabetic retinopathy study: good news for diabetic patients and health care professionals [editorial]. Diabetes Care 1986; 9: 426–9.

    PubMed  CAS  Google Scholar 

  31. Lewis EJ, Hunsicker LG, Bain RE, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456–62.

    Article  PubMed  CAS  Google Scholar 

  32. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. Lancet 2000; 342: 145–53.

    Google Scholar 

  33. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE sub-study. Lancet 2000; 345: 253–9.

    Google Scholar 

  34. Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA. Effect of strict glycemic control on renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 1626–32.

    Article  PubMed  CAS  Google Scholar 

  35. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000; 283: 1967–75.

    Article  Google Scholar 

  36. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 2001; 285: 2486–97.

    Article  Google Scholar 

  37. Flynn MD, Tooke JE. Aetiology of diabetic foot ulceration: a role for the microcirculation? Diabetic Med 1992; 9: 320–9.

    Article  PubMed  CAS  Google Scholar 

  38. Skyler JS. Insulin treatment: therapy for diabetes mellitus and related disorders. Alexandria, VA: American Diabetes Association, 1991; 127–37.

    Google Scholar 

  39. Chan NH, Baldeweg S, Tan TMM, Hurel SI. Inhaled insulin in type 1 diabetes. Lancet 2001; 357: 1979.

    Article  PubMed  CAS  Google Scholar 

  40. Bhatia V, Wolfsdorf JI. Severe hypoglycemia in youth with insulin-dependent diabetes mellitus: frequency and causative factors. Pediatrics 1991; 88: 1187–93.

    PubMed  CAS  Google Scholar 

  41. UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352 (9131): 854–65.

    Article  Google Scholar 

  42. Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 2001; 103: 346–7.

    Article  Google Scholar 

  43. Tuomilehto J, Lindstorm J, Eirksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–50.

    Article  PubMed  CAS  Google Scholar 

  44. Groop LC, Widèn E, Ekstrand A, et al. Morning or bedtime NPH insulin combined with sulfonylureas in treatment of NIDDM. Diabetes Care 1992; 15: 831–4.

    Article  PubMed  CAS  Google Scholar 

  45. Proceedings of the Third International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes 1991; 40 (suppl 2): 1–201.

    Google Scholar 

  46. Jovanovic-Peterson L, Peterson CM. Pregnancy in the diabetic woman: guidelines for a successful outcome. Endocrinol Metab Clin North Am 1992; 33: 433–56.

    Google Scholar 

  47. Kaufmann RC, Amankwah KS, Woodrum J. Development of diabetes in previous gestational diabetic [abstract]. Diabetes 1991; 40: 137A.

    Google Scholar 

  48. Kaufmann RC, Amankwah KS, Woodrum J. Serum lipids in former gestational diabetics [abstract]. Diabetes 1991; 40: 192A.

    Google Scholar 

  49. Kozak GP, Rolla AR. Diabetic comas. In: Kozak GP, ed. Clinical diabetes mellitus. Philadelphia: Saunders, 1982; 109–45.

    Google Scholar 

  50. Siperstein MD. Diabetic ketoacidosis and hyperosmolar coma. Endocrinol Metab Clin North Am 1992; 33: 415–32.

    Google Scholar 

Download references

Authors
  1. Charles Kent Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John P. Sheehan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margaret M. Ulchaker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oregon Health & Science University School of Medicine, Portland, Oregon, USA

    Robert B. Taylor M.D. (Professor of Family Medicine) (Professor of Family Medicine)

  2. Department of Family and Community Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Alan K. David M.D. (Professor and Chairman) (Professor and Chairman)

  3. Department of Family Medicine, Oregon Health & Science University School of Medicine, Portland, Oregon, USA

    Scott A. Fields M.D. (Professor and Vice Chairman) (Professor and Vice Chairman)

  4. Department of Family Medicine, University of Mississippi School of Medicine, Jackson, Mississippi, USA

    D. Melessa Phillips M.D. (Professor and Chairman) (Professor and Chairman)

  5. College of Medicine, Florida State University College of Medicine, Tallahassee, Florida, USA

    Joseph E. Scherger M.D., M.P.H. (Dean) (Dean)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Smith, C.K., Sheehan, J.P., Ulchaker, M.M. (2003). Diabetes Mellitus. In: Taylor, R.B., David, A.K., Fields, S.A., Phillips, D.M., Scherger, J.E. (eds) Fundamentals of Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-21745-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-21745-1_20

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95479-0

  • Online ISBN: 978-0-387-21745-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation